Jinling Pharmaceutical Co Ltd (000919) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.17x

Jinling Pharmaceutical Co Ltd (000919) has a Cash Flow Reinvestment Rate of 0.17x as of September 2025, reinvesting CN¥12.56 Million (capex CN¥12.56 Million ) from operating cash flow of CN¥74.01 Million. Check 000919 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.17x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥12.56 Million
Capex + Investments

Operating Cash Flow

CN¥74.01 Million
CNY

Capital Expenditures

CN¥12.56 Million
CNY

Jinling Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2024)

Historical reinvestment intensity for Jinling Pharmaceutical Co Ltd across 26 annual periods. Explore 000919 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Jinling Pharmaceutical Co Ltd (1999–2024)

Year-by-year capital reinvestment analysis for Jinling Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market cap of Jinling Pharmaceutical Co Ltd.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 4.80x CN¥739.80 Million CN¥154.19 Million CN¥201.63 Million ▲ +80.7%
2023 2.65x CN¥421.94 Million CN¥158.92 Million CN¥186.25 Million ▲ +30.4%
2022 2.04x CN¥530.76 Million CN¥260.59 Million CN¥309.64 Million ▲ +264.2%
2021 0.56x CN¥163.32 Million CN¥292.03 Million CN¥162.76 Million ▼ -57.7%
2020 1.32x CN¥412.12 Million CN¥311.46 Million CN¥291.41 Million ▲ +104.1%
2019 0.65x CN¥302.01 Million CN¥465.85 Million CN¥125.71 Million ▲ +4.0%
2018 0.62x CN¥270.52 Million CN¥433.83 Million CN¥136.42 Million ▲ +259.1%
2017 0.17x CN¥76.94 Million CN¥443.11 Million CN¥66.80 Million ▼ -87.0%
2016 1.34x CN¥128.57 Million CN¥96.15 Million CN¥107.45 Million ▲ +56.2%
2015 0.86x CN¥181.83 Million CN¥212.45 Million CN¥104.31 Million ▲ +181.6%
2014 0.30x CN¥91.14 Million CN¥299.89 Million CN¥91.14 Million ▼ -42.8%
2013 0.53x CN¥144.05 Million CN¥271.21 Million CN¥144.05 Million ▼ -34.7%
2012 0.81x CN¥188.76 Million CN¥232.12 Million CN¥188.76 Million ▲ +71.0%
2011 0.48x CN¥82.20 Million CN¥172.82 Million CN¥82.20 Million ▼ -11.4%
2010 0.54x CN¥95.48 Million CN¥177.81 Million CN¥95.48 Million ▲ +4.7%
2009 0.51x CN¥96.60 Million CN¥188.41 Million CN¥96.60 Million ▲ +607.8%
2008 0.07x CN¥22.11 Million CN¥305.26 Million CN¥22.11 Million ▼ -59.2%
2007 0.18x CN¥20.97 Million CN¥118.06 Million CN¥20.97 Million ▲ +6.5%
2006 0.17x CN¥23.09 Million CN¥138.50 Million CN¥23.09 Million ▼ -50.2%
2005 0.33x CN¥36.61 Million CN¥109.29 Million CN¥36.61 Million ▼ -26.1%
2004 0.45x CN¥72.47 Million CN¥159.81 Million CN¥72.47 Million ▲ +29.4%
2003 0.35x CN¥56.73 Million CN¥161.86 Million CN¥56.73 Million ▼ -55.5%
2002 0.79x CN¥102.63 Million CN¥130.36 Million CN¥102.63 Million ▼ -54.6%
2001 1.73x CN¥160.27 Million CN¥92.49 Million CN¥160.27 Million ▲ +198.0%
2000 0.58x CN¥134.49 Million CN¥231.31 Million CN¥134.49 Million ▼ -67.7%
1999 1.80x CN¥71.57 Million CN¥39.77 Million CN¥71.57 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow